Stay updated on IGN002 Dose-Escalation Study in NHL Clinical Trial

Sign up to get notified when there's something new on the IGN002 Dose-Escalation Study in NHL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IGN002 Dose-Escalation Study in NHL Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The record displays details for the Phase 1 IGN002 study in non-Hodgkin lymphoma, including its terminated status, eligibility criteria, study design, locations, and outcome measures.
    Difference
    36%
    Check dated 2026-11-11T02:25:00.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T01:16:56.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    An NIH-wide banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence,” and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T01:11:34.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-07T01:18:06.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Access to the study page is blocked with a 403 Forbidden error, replacing the record content. The error page obscures the study details and navigation that were previously visible.
    Difference
    16%
    Check dated 2026-09-23T01:09:48.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page’s Revision line was updated from v3.6.6 to v3.7.0, signaling a newer version of the page. This appears to be a versioning or content update rather than a change to study results, eligibility, or participation details.
    Difference
    0.1%
    Check dated 2026-09-16T00:24:35.000Z thumbnail image

Stay in the know with updates to IGN002 Dose-Escalation Study in NHL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IGN002 Dose-Escalation Study in NHL Clinical Trial page.